Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials

Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials

Abstract Background The aim of the study was to estimate the minimally important difference (MID) for interpreting group-level change over time, both within a group and between groups, for the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ...

Full description

Bibliographic Details
Main Authors: Eva M. Gamper, Jammbe Z. Musoro, Corneel Coens, Jean-Jacques Stelmes, Claudette Falato, Mogens Groenvold, Galina Velikova, Kim Cocks, Hans-Henning Flechtner, Madeleine T. King, Andrew Bottomley, on behalf of the EORTC Genito-Urinary Tract Cancer Group and Quality of Life Groups
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Cancer
Subjects:
Health-related quality of life
HRQOL
HRQL
Interpretation of scores
MIDs
Patient-reported outcomes
Online Access:https://doi.org/10.1186/s12885-021-08609-7

Internet

https://doi.org/10.1186/s12885-021-08609-7

Similar Items